← Back
$APLS All transactions

Apellis Pharmaceuticals, Inc.

A

$ Value

$0

Shares

14,312

Price

$0

Filed

Mar 3

Insider

Name

Dolsten Mikael

Title

CIK

0001437590

Roles

Director

Transaction Details

Transaction Date

2026-02-27

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

14,312

Footnotes

This restricted stock unit was granted on February 27, 2026. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to his continued service as a director, or upon later termination of his service as a director at his election. | This represents a stock option award granted February 27, 2026 that vest 1/3rd per year over a three-year period subject to continued service.

Filing Info

Accession No.

0001492422-26-000092

Form Type

4

Issuer CIK

0001492422

Dolsten Mikael's History

Date Ticker Type Value
2026-03-19 A A $241K
2026-02-27 APLS A $0
2026-02-27 APLS A $506K
2025-12-01 A $390K
2025-06-18 RCKT A $0
2025-03-05 RCKT J $0

Other Insiders at APLS (90d)

Insider Bought Sold Last
Dolsten Mikael 2026-02-27
Watson David O.
General Counsel
2026-01-28
Deschatelets Pascal
Chief Scientific Officer
2026-01-28
Francois Cedric
Chief Executive Officer
2026-03-11
Sullivan Timothy Eugene
Chief Financial Officer
2026-04-17
O'Brien Stephanie Monaghan 2026-04-06
Nicholson Nur
Chief Technical Officer
2026-01-28
Chopas James George
VP/Chief Accounting Officer
2026-01-28
DeLong Mark Jeffrey
Chief Business & Strat Officer
$8K 2026-02-11
Boucher Kelley
Chief People Officer
2026-01-28
MELTZER LESLIE
Chief Research and Development
2026-01-28